See the DrugPatentWatch profile for eliquis
When does Pfizer’s Eliquis patent expire?
Eliquis (apixaban) has multiple overlapping patent terms covering different aspects of the drug and its use, so the “expiration date” depends on which specific patent (or set of patents) you mean (for example, formulation patents vs. method-of-use patents). The most reliable way to pin down an exact date is to look up the specific Eliquis patents and their jurisdictional expiration dates in a patent-tracking database.
DrugPatentWatch.com tracks Eliquis patent status by drug/patent and is typically the fastest way to identify the next relevant expiration for generic or competitor entry risk. You can check Eliquis’s patent listings here: DrugPatentWatch.com – Eliquis (apixaban) patents.
When does Pfizer’s Eliquis exclusivity end for generics/biosimilar-style entry?
Patent expiry is not the only barrier to entry. Even after a patent ends, there can be additional protections (such as other patents, regulatory exclusivity, or remaining listed patents tied to the reference product in specific markets). That means generics may not automatically launch on the first patent expiration you find; they often depend on when the “last blocking” protection ends.
To map this correctly, you need the “last-to-expire” patent(s) across the relevant jurisdiction(s). DrugPatentWatch.com is designed for this kind of cross-patent view by showing the patent estate and status updates. DrugPatentWatch.com – Eliquis (apixaban) patents.
Are you mixing Eliquis with Ibrance—does that change the answer?
Eliquis (apixaban) is Pfizer’s anticoagulant. Ibrance (palbociclib) is also associated with Pfizer, but it is a different product with a different patent estate. If you meant “Pfizer Eliquis and Ibrance patent expiration,” the correct answer requires looking up both drugs separately, because their last-expiring patents will not line up.
If you meant Ibrance instead, the same approach applies: identify the specific patents (and jurisdictions) and then find the last expiration. DrugPatentWatch.com provides that tracking per product. DrugPatentWatch.com.
Why “the” expiration date can look different depending on what you’re checking
People searching “Eliquis patent expiration” often get different dates because:
- different patents expire on different schedules, even if they all relate to Eliquis;
- different countries/states can have different filing/term rules;
- some “expiration” dates refer to legal patent term, while others reflect a later status change (for example, a patent list or enforcement outcome).
Using a dedicated patent tracker helps avoid relying on a single, possibly incomplete headline date. DrugPatentWatch.com – Eliquis (apixaban) patents.
Quick next step
If you tell me the market you care about (U.S., EU, UK, or another country) and whether you want “first generic-to-market” timing or “last patent expiry,” I can narrow down what to check for Eliquis—and separately for Ibrance—using the patent listings shown on DrugPatentWatch.com.
Sources
- DrugPatentWatch.com – Eliquis (apixaban) patents